Proteostasis Therapeutics Inc. (PTI)

3.13
NASDAQ : Health Technology
Prev Close 3.13
Day Low/High 0.00 / 0.00
52 Wk Low/High 1.41 / 16.67
Avg Volume 1.40M
Exchange NASDAQ
Shares Outstanding 33.11M
Market Cap 96.03M
EPS -2.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

That Wild Market Momentum Has Cooled

That Wild Market Momentum Has Cooled

But here are some movers I am looking at today.

Proteostasis Therapeutics Reports Preliminary Data From Phase 1 Study Of PTI-428 In Patients With Cystic Fibrosis

Proteostasis Therapeutics Reports Preliminary Data From Phase 1 Study Of PTI-428 In Patients With Cystic Fibrosis

Screening Initiated in Phase 2 Portion of PTI-428 Study, 28-day Dosing Cohort

Proteostasis Therapeutics Announces Clinical And Regulatory Progress Across Pipeline Programs

Updates Announced During the 40th European Cystic Fibrosis Society Conference

Oversold Conditions For Proteostasis Therapeutics (PTI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: DISCK, FOR, FPI, IAG, TITN Downgrades: PATI, SCKT, TCRD, TRC, UBP Initiations: PTI Read on to get TheStreet Quant Ratings' detailed report:

RSI Alert: Proteostasis Therapeutics (PTI) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies are scooping up shares of their own stock lately.

Proteostasis Therapeutics Announces Scientific Presentations On New Data At 30th Annual North American Cystic Fibrosis Conference

Proteostasis Therapeutics Announces Scientific Presentations On New Data At 30th Annual North American Cystic Fibrosis Conference

Company to Host Analyst and Investor Event Thursday, Oct. 27 at 8:00 p.m. ET

PTI Crosses Above Average Analyst Target

PTI Crosses Above Average Analyst Target

In recent trading, shares of Proteostasis Therapeutics Inc have crossed above the average analyst 12-month target price of $17.00, changing hands for $19.41/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Proteostasis Therapeutics Issues Mid-Year Corporate Update On Cystic Fibrosis Pipeline Programs

Proteostasis Therapeutics Issues Mid-Year Corporate Update On Cystic Fibrosis Pipeline Programs

Preliminary Biomarker Data Confirms PTI-428 Activity on CFTR mRNA in Human Subjects

TheStreet Quant Rating: D (Sell)